Antiatherosclerotic effects of sitagliptin in type 2 diabetics with or without insulin
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2012
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary) ; Insulins
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 24 Nov 2012 New trial record
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 05 Nov 2012 Primary endpoint 'Flow-mediated-dilation' has been met.